Drug Shortage Report for ACETYLCYSTEINE SOLUTION

Last updated on 2024-01-04 History
Report ID 212999
Drug Identification Number 02243098
Brand name ACETYLCYSTEINE SOLUTION
Common or Proper name ACETYLCYSTEINE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ACETYLCYSTEINE
Strength(s) 200MG
Dosage form(s) SOLUTION
Route of administration ORAL INTRAVENOUS INHALATION ORAL INTRAVENOUS INHALATION
Packaging size 30ML
ATC code R05CB
ATC description EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-12-11
Estimated end date 2023-12-22
Actual end date 2024-01-03
Shortage status Resolved
Updated date 2024-01-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-12-11 English Compare
v2 2023-12-11 French Compare
v3 2023-12-12 English Compare
v4 2024-01-03 English Compare
v5 2024-01-03 French Compare
v6 2024-01-04 English Compare

Showing 1 to 6 of 6